Apollomics, Inc. (previously CBT Pharmaceuticals, Inc.) Raises $100 Million in Series B Financing Jan 8, 2019 Life Science
CANbridge Pharmaceuticals and GC Pharma Announce Greater China Licensing Agreement for Hunterase™ for Hunter Syndrome Jan 8, 2019 Life Science
Apic Bio Announces $40M Series A Financing to Advance Novel Gene Therapies for Rare Genetic Disorders Jan 7, 2019 Life Science
Schrödinger Closes $85 Million Financing to Advance Computational Platform and Expand Drug Discovery Pipeline Jan 7, 2019 Life Science
OrigiMed Completes Series B Round Focusing on Creating a Comprehensive Precision Medicine Platform for Oncology Jan 4, 2019 Life Science
Athenex Out-Licenses China Rights to Keratosis/Oncology Drug for $29.5 Million Jan 4, 2019 Life Science
StemCyte Receives Phase II Investigational New Drug (IND) Clearance from the U.S. Food and Drug Administration (FDA) Jan 3, 2019 Life Science
China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering Jan 3, 2019 Life Science
Promega Microsatellite Instability Technology Receives Innovation Designation from Chinese National Medical Products Administration Jan 2, 2019 Life Science
